UC DIS.CERT. 02/25 FRE/ DE000HD48TB1 /
10/01/2025 09:00:51 | Chg.+0.020 | Bid09:20:24 | Ask- | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
19.890EUR | +0.10% | 19.920 Bid Size: 35,000 |
- Ask Size: - |
FRESENIUS SE+CO.KGAA... | - - | 28/02/2025 | Call |
GlobeNewswire
24/04/2024
Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) for ...
GlobeNewswire
23/04/2024
Transferring Biomedical Research to Patients Faster: ForTra gGmbH Announces Positive Funding Track R...
GlobeNewswire
23/02/2024
Travere Therapeutics and CSL Vifor Announce Sparsentan Receives Positive CHMP Opinion for the Treatm...
GlobeNewswire
04/09/2023
CIO Leadership: Generative AI and Visionary Leadership in the Enterprise Will Power the Discussion a...
GlobeNewswire
31/08/2023
CytoSorbents Granted Expanded ANVISA Registration to Treat Shock with CytoSorb in Brazil